CC531 Cells
CAD$1,104.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | CC531 is a well-characterized rat adenocarcinoma cell line derived from the colon. It was originally established from a chemically induced colon tumor in a Wistar rat using 1,2-dimethylhydrazine (DMH), a potent carcinogen. The CC531 cell line is commonly utilized as a model system to study colorectal cancer mechanisms and the tumor microenvironment in vivo, particularly within the context of metastasis and immune responses. These cells are immunogenic and are often used in syngeneic rat models to investigate the efficacy of cancer immunotherapies and the interaction between cancer cells and the immune system. In research settings, CC531 cells are employed to examine the biological processes of colorectal cancer progression, including cell proliferation, apoptosis, and metastatic behavior. The cell line has been instrumental in studying the response of colorectal cancer to various chemotherapeutic agents and radiation therapy, providing insights into the mechanisms of resistance and sensitivity to cancer treatments. Moreover, the CC531 model serves as a valuable tool for the development and optimization of novel therapeutic strategies targeting colorectal cancer, making it crucial for translational cancer research. |
|---|---|
| Organism | Rat |
| Tissue | Colon |
| Disease | Adenocarcinoma |
| Synonyms | CC-531 |
Characteristics
| Breed/Subspecies | WAG rats |
|---|---|
| Growth properties | Adherent |
Regulatory Data
| Citation | CC531 (Cytion catalog number 500387) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10116 |
| CellosaurusAccession | CVCL_0206 |
Biomolecular Data
| Tumorigenic | Yes, in nude mice, syngeneic WAG-Rij rats |
|---|
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS, 20 mM HEPES |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 1 to 2 x 104 cells/cm2 will result in a confluent monolayer within 3 to 4 days. |
| Fluid renewal | 2 to 3 times per week |
| Post-Thaw Recovery | After thawing, plate the cells at 5 x 104 cells/cm2 and allow the cells to recover from the freezing process and to adhere for at least 48 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 500387-118s | Certificate of Analysis | 23. May. 2025 | 500387 |